Αρχική World News FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and Older... World News FDA Approves Selumetinib for Paediatric Patients 1 Year of Age and Older with Neurofibromatosis Type 1 with Symptomatic, Inoperable Plexiform Neurofibromas Από Ogkologos - 25 Σεπτεμβρίου, 2025 504 0 Facebook Twitter Google+ Pinterest WhatsApp Approval was based on findings from the Study 89, SPRINT and the SPRINKLE trials Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Novel T-cell-based therapies are demonstrating strong and durable responses in solid... 27 Οκτωβρίου, 2026 11 Children Orphaned and Unable to Pay for Funeral After Their... 25 Απριλίου, 2019 Giving Myself the Most Time and Best Chance at Beating Cancer:... 10 Οκτωβρίου, 2023 How I Navigated Being a Young Mom During Cancer: A Survivor’s... 15 Φεβρουαρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Teacher on Leave for Breast Cancer Treatment Forced to Pay for... Patient Guide in Colorectal Cancer Now Available in Bulgarian Dad Gets Tattoo On His Chest To Match Daughter’s Scar So... Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance